BNP Paribas Asset Management
FLGT icon

BNP Paribas Asset Management’s Fulgent Genetics FLGT Stock Holding History

BNP Paribas Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-803
Closed -$12.8K – 2287
2026
Q1 		$12.8K Buy
803
+303
+61% +$6.58K ﹤0.01% 2154
2025
Q4 		$13K Buy
500
+48
+11% +$1.25K ﹤0.01% 2069
2025
Q3 		$10K Buy
452
+167
+59% +$3.44K ﹤0.01% 1629
2025
Q2 		$6K Buy
+285
New +$5.55K ﹤0.01% 1932

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BNP Paribas Asset Management's FLGT Position: Q2 2026 in Review

BNP Paribas Asset Management sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 803 shares — an estimated $12.8K sold.

BNP Paribas Asset Management first reported a position in FLGT in Q2 2025 and held it in 4 quarters. The position peaked at $13K in Q4 2025. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • BNP Paribas Asset Management reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • BNP Paribas Asset Management sold 803 Fulgent Genetics shares in Q2 2026, an estimated $12.8K.
  • BNP Paribas Asset Management first reported a position in Fulgent Genetics in Q2 2025 and held it in 4 quarters.
  • BNP Paribas Asset Management's Fulgent Genetics position peaked at $13K in Q4 2025.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.